Tag: biosimilars

Planning for Patent Expiry: What Patients and Healthcare Systems Need to Do Now

Planning for Patent Expiry: What Patients and Healthcare Systems Need to Do Now

Patent expiry means cheaper drugs-but only if you plan ahead. Learn what patients and healthcare systems must do now to avoid disruptions and save money when brand-name medications lose exclusivity.

The Purple Book: Understanding Biosimilars and Interchangeability from the FDA

The Purple Book: Understanding Biosimilars and Interchangeability from the FDA

The FDA's Purple Book is the official database for biosimilars and interchangeable biological products. Learn how it works, which products are substitutable, and why state laws still control pharmacy substitutions.